Home › Trial NCT00516152
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
- Trial IDNCT00516152
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of California, San Francisco
- Enrollment36
- Start date2002-11
- ConditionsChronic Myeloid Leukemia · Acute Myelogenous Leukemia · Myelodysplasia · Acute Lymphocytic Leukemia · Severe Aplastic Anemia · Non-Hodgkin's Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.